|
|
|
|
LEADER |
00849nam a2200217 a 4500 |
001 |
1788997 |
005 |
20171111234536.0 |
008 |
130306s2013 gw ac sb 001 0 eng d |
020 |
|
|
|z 9783527330737
|
040 |
|
|
|a CaPaEBR
|z 9783527651115 (e-book)
|
050 |
1 |
4 |
|a RM301.25
|b .A53 2013eb
|
245 |
0 |
0 |
|a Analogue-based drug discovery III
|c edited by Jβanos Fischer, C. Robin Ganellin and David P. Rotella.
|
260 |
|
|
|a Weinheim, Germany :
|b Wiley-VCH,
|c 2013.
|
300 |
|
|
|a xviii, 385 p. :
|b ill., ports.
|
504 |
|
|
|a Includes bibliographical references and index.
|
505 |
0 |
|
|a pt. 1. General aspects -- pt. 2. Drug classes -- pt. 3. Case studies.
|
650 |
|
0 |
|a Drug development.
|
700 |
1 |
|
|a Ganellin, C. R.
|
710 |
2 |
|
|a ebrary, Inc.
|
856 |
4 |
0 |
|u http://site.ebrary.com/lib/ucy/Doc?id=10662582
|
952 |
|
|
|a CY-NiOUC
|b 5a0457e26c5ad14ac1ed03db
|c 998a
|d 945l
|e -
|t 1
|x m
|z Books
|